Oligosaccharide / biegunka

Use of indigestible oligosaccharides to prevent gastrointestinal infections and reduce duration of diarrhea in humans

Tylko zarejestrowani użytkownicy mogą tłumaczyć artykuły

Zaloguj się Zarejestruj się

This application claims the benefit of U.S. Provisional Application No. 60/001,036, filed Jul. 11, 1995. FIELD OF THE INVENTION The present invention relates to a method of reducing duration of diarrhea by enterally administering to humans indigestible oligosaccharides. BACKGROUND OF THE

Methods for the treatment and prevention of diarrhea

Tylko zarejestrowani użytkownicy mogą tłumaczyć artykuły

Zaloguj się Zarejestruj się

TECHNICAL FIELD The present invention relates to a method for the treatment and prevention of diarrhea comprising administering to humans a sugar selected from the group consisting of a caramel composition comprising a high content of fructose oligosaccharides, termed sucrose thermal

Oral rehydration solution containing indigestible oligosaccharides

Tylko zarejestrowani użytkownicy mogą tłumaczyć artykuły

Zaloguj się Zarejestruj się

FIELD OF THE INVENTION This invention relates to an oral rehydration solution containing indigestible oligosaccharides for the inhibition of disease states associated with Clostridium difficile. BACKGROUND OF INVENTION The successful management of acute diarrhea is still a challenge today. Acute

Inhibition of C. difficile infections by indigestible oligosaccharides

Tylko zarejestrowani użytkownicy mogą tłumaczyć artykuły

Zaloguj się Zarejestruj się

FIELD OF THE INVENTION This invention relates to the use of indigestible oligosaccharides in the inhibition of disease states by Clostridium difficile. BACKGROUND OF INVENTION Clostridium difficile (C. difficile) is the leading known cause of nosocomial infections. Greenough et al., "Diarrhea in the

Treatment of traveller's diarrhea

Tylko zarejestrowani użytkownicy mogą tłumaczyć artykuły

Zaloguj się Zarejestruj się

FIELD OF THE INVENTION This invention relates to treatment of traveller's diarrhea, including diarrhea caused by enterotoxigenic Escherichia coli (ETEC). More specifically, the invention concerns neutralization and removal of E. coli heat-labile toxin (LT) associated with ETEC. This invention also

Treatment of traveller's diarrhea

Tylko zarejestrowani użytkownicy mogą tłumaczyć artykuły

Zaloguj się Zarejestruj się

FIELD OF THE INVENTION This invention relates to treatment of traveller's diarrhea, including diarrhea caused by enterotoxigenic Escherichia coli (ETEC). More specifically, the invention concerns neutralization and removal of E. coli heat-labile toxin (LT) associated with ETEC. This invention also

Treatment of traveller's diarrhea

Tylko zarejestrowani użytkownicy mogą tłumaczyć artykuły

Zaloguj się Zarejestruj się

FIELD OF THE INVENTION This invention relates to treatment of traveller's diarrhea, including diarrhea caused by enterotoxigenic Escherichia coli (ETEC). More specifically, the invention concerns neutralization and removal of E. coli heat-labile toxin (LT) associated with ETEC. This invention also

Treatment of diarrhea caused by enteropathogenic Escherichia coli

Tylko zarejestrowani użytkownicy mogą tłumaczyć artykuły

Zaloguj się Zarejestruj się

FIELD OF THE INVENTION This invention relates to treatment of diarrhea, particularly diarrhea caused by enteropathogenic Escherichia coli (EPEC). More specifically, the invention concerns compositions and methods which may be used to prevent EPEC infection or ameliorate symptoms caused by EPEC

Treatment of antibiotic associated diarrhea

Tylko zarejestrowani użytkownicy mogą tłumaczyć artykuły

Zaloguj się Zarejestruj się

FIELD OF THE INVENTION This invention relates to treatment of antibiotic associated diarrhea, including Clostridium difficile associated diarrhea (CDAD) and pseudomembranous colitis (PMC). More specifically, the invention concerns neutralization of C. difficile toxin A associated with

Treatment of traveller's diarrhea

Tylko zarejestrowani użytkownicy mogą tłumaczyć artykuły

Zaloguj się Zarejestruj się

FIELD OF THE INVENTION This invention relates to treatment of traveller's diarrhea, including diarrhea caused by enterotoxigenic Escherichia coli (ETEC). More specifically, the invention concerns neutralization and removal of E. coli heat-labile toxin (LT) associated with ETEC. This invention also

Compounds and methods for the treatment of bacterial dysentery using antibiotics and toxin binding oligosaccharide compositions

Tylko zarejestrowani użytkownicy mogą tłumaczyć artykuły

Zaloguj się Zarejestruj się

BACKGROUND OF THE INVENTION Field of the Invention This invention relates to the treatment of diarrhea and related conditions caused by pathogenic E. coli infection. More specifically, this invention is drawn to the unexpected discovery that by administering a composition which binds and removes the

Lactobacillus bifidus growth promoting composition and use thereof

Tylko zarejestrowani użytkownicy mogą tłumaczyć artykuły

Zaloguj się Zarejestruj się

TECHNICAL FIELD The present invention pertains to a composition that can be orally administered to bring intestinal flora to a good state and efficiently control intestinal function, and the use thereof. In further detail, the present invention pertains to a Lactobacillus bifidus growth promoting

Prebiotic compositions

Tylko zarejestrowani użytkownicy mogą tłumaczyć artykuły

Zaloguj się Zarejestruj się

The present invention concerns prebiotic compositions comprising of soluble fibres, in particular fructo-oligosaccharides (FOS) and galacto-oligosaccharides (GOS), and their use in the treatment or prevention of gastrointestinal tract disorders, such as inflammatory bowel disease (IBD), diarrhoea

Prebiotic compositions

Tylko zarejestrowani użytkownicy mogą tłumaczyć artykuły

Zaloguj się Zarejestruj się

The present invention concerns prebiotic compositions comprising of soluble fibres, in particular fructo-oligosaccharides (FOS) and galacto-oligosaccharides (GOS), and their use in the treatment or prevention of gastrointestinal tract disorders, such as inflammatory bowel disease (IBD), diarrhoea

Method of binding and removing toxin A

Tylko zarejestrowani użytkownicy mogą tłumaczyć artykuły

Zaloguj się Zarejestruj się

FIELD OF THE INVENTION This invention relates to treatment of antibiotic associated diarrhea, including Clostridium difficile associated diarrhea (CDAD) and pseudomembranous colitis (PMC). More specifically, the invention concerns neutralization of C. difficile toxin A associated with

oligosaccharide/biegunka

Use of indigestible oligosaccharides to prevent gastrointestinal infections and reduce duration of diarrhea in humans

Methods for the treatment and prevention of diarrhea

Oral rehydration solution containing indigestible oligosaccharides

Inhibition of C. difficile infections by indigestible oligosaccharides

Treatment of traveller's diarrhea

Treatment of traveller's diarrhea

Treatment of traveller's diarrhea

Treatment of diarrhea caused by enteropathogenic Escherichia coli

Treatment of antibiotic associated diarrhea

Treatment of traveller's diarrhea

Compounds and methods for the treatment of bacterial dysentery using antibiotics and toxin binding oligosaccharide compositions

Lactobacillus bifidus growth promoting composition and use thereof

Prebiotic compositions

Prebiotic compositions

Method of binding and removing toxin A

Najbardziej kompletna baza danych ziół leczniczych poparta naukowo